What do you think?
Rate this book


272 pages, Paperback
First published January 1, 2013
For as long as there has been a Diagnostic and Statistical Manual of Mental Disorders (DSM), it has been treated as if it contained scientific truths. Yet, is that what the DSM really is? Or, is it really only a rough draft of diagnoses based on the supposed consensus of experts? This seems to be the question that drives the explanation and critique forwarded by Dr.Joel Paris in The Intelligent Clinician's Guide to the DSM-5.
A good place to start is to envision a mental disorder as similar to that of a medical diagnosis; viz., that both require scientific classification. However, the differences arise in that mental disorders lack the more fundamental understanding of disease processes. Mental disorders are based more on signs and symptoms which lack the requisite biological markers to obtain validity in science. Therefore, a psychiatric diagnosis should not be considered real in the same way as described for a medical disease. The consequence of labeling people with a normal spectrum of thoughts, behaviors, and emotions as mentally ill, could lead to stigmatizing and unnecessary treatment. Curiously, what is normal, and who decides that criteria?!
Dr. Paris begins by taking the reader on a brief journey through the history of psychiatric diagnoses and then delves into explaining why DSMs are made. It is in this section of the book that the reader can recognize the intricate, and somewhat disturbing, patterns that led up to the current edition, Diagnostic and Statistical Manual of Mental Disorders ( The Guide of the Perplexed). The point is that the whole system of diagnosing and treating mental disorders is perplexing, and as in the case of the DSM-V®, “psychiatry should not and cannot make radical revisions until it learns more about the etiology if mental illness” (p. 183).
I will end with one of the more penetrating paragraphs of the book,
“We are told, without solid evidence, that millions of people with mental symptoms are tragically undertreated. Again, the subtext is drugs. Although it is true that some patients with severe disorders are not getting the help they need, mild or subclinical symptoms may not need the same treatment or any treatment at all. The thrust of these arguments, usually based on epidemiological data, is that drugs should be prescribed to an even larger percentage of the population than is already the case. The pharmaceutical industry can only rejoice at such conclusions. The rest of us are left to weep” (p. 185).
And, weep we shall…
Happy Reading!